Clinical Trial

A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software in Participants With PsAF

Study acronym: VP-EXTRA
Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to investigate the workflow of the clinical use of the pulsed field (PF) ablation system (VARIPULSE catheter and TRUPULSE generator) when used for cardiac ablation with the new VARIPULSE Pro software in participants with persistent atrial fibrillation (PsAF; irregular, rapid heart rhythm that lasts over 7 days and doesn't stop on its own)
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-07-08
critical Recruitment opened 2026-06-06
Trial Details
NCT Number NCT07428564
Lead Sponsor Biosense Webster, Inc.
Conditions Atrial Fibrillation
Enrollment 50 participants
Start Date 2026-05-19
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07